← All companies
VICP
Vicapsys Life Sciences, Inc.
$1.45
+0.00 0.00%
Key statistics
from XBRL data in SEC filingsMarket cap
$49.8M
Revenue (TTM)
—
Net income (TTM)
-$1.35M
EPS (TTM)
$-0.04
P/E ratio
—
Dividend yield
—
Free cash flow
—
Cash
$89.6K
Total assets
$89.6K
Gross margin
—
52-week range
$0.15 – $1.77
Recent SEC filings
40 most recentAnnual, quarterly & current reports
10-Q
Quarter ended 2024-09-30
Jan 10, 2025
10-Q
Quarter ended 2024-06-30
Jan 10, 2025
10-Q
Quarter ended 2024-03-31
Jan 10, 2025
10-K
Fiscal year ended 2023-12-31
Oct 21, 2024
8-K
Entered a material agreement; Took on a direct financial obligation
Dec 27, 2023
10-Q
Quarter ended 2023-09-30
Nov 14, 2023
10-Q
Quarter ended 2023-06-30
Aug 14, 2023
8-K
Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity
Jun 30, 2023
8-K
Entered a material agreement
Jun 2, 2023
8-K/A
Changed accountants
May 18, 2023
8-K
Changed accountants
May 17, 2023
10-Q
Quarter ended 2023-03-31
May 15, 2023
10-K
Fiscal year ended 2022-12-31
Apr 14, 2023
8-K
Director or officer change
Jan 12, 2023
10-Q
Quarter ended 2022-09-30
Nov 21, 2022
8-K
Director or officer change
Sep 28, 2022
10-Q
Quarter ended 2022-06-30
Aug 16, 2022
10-Q
Quarter ended 2022-03-31
May 13, 2022
8-K
Director or officer change; Other events
Apr 12, 2022
10-K
Fiscal year ended 2021-12-31
Mar 16, 2022
10-Q
Quarter ended 2021-09-30
Nov 12, 2021
10-Q
Quarter ended 2021-06-30
Sep 20, 2021
10-Q
Quarter ended 2021-03-31
Sep 20, 2021
10-K
Fiscal year ended 2020-12-31
Sep 17, 2021
10-Q
Quarter ended 2020-09-30
Sep 13, 2021
10-Q
Quarter ended 2020-06-30
Sep 9, 2021
10-Q
Quarter ended 2020-03-31
May 15, 2020
10-Q
Quarter ended 2010-06-30
Aug 24, 2010
8-K/A
Completed an acquisition or disposition
Jul 29, 2010
8-K
Director or officer change
Jul 1, 2010
10-Q
Quarter ended 2010-03-31
Jun 22, 2010
10-K
Fiscal year ended 2009-12-31
May 24, 2010
8-K
Completed an acquisition or disposition; Unregistered sale of equity
May 18, 2010
8-K
Terminated a material agreement; Director or officer change
Apr 26, 2010
8-K
Director or officer change
Apr 12, 2010
8-K
Other events
Dec 9, 2009
Other filings
15-12G
Mar 27, 2025
SCHEDULE 13G
Mar 21, 2025
3
Mar 21, 2025
SEC STAFF ACTION
Jun 27, 2024